NCT04994899 is a clinical trial in Depression, sponsored by Aiberry, Inc.

Who is sponsoring NCT04994899?

NCT04994899 is sponsored by Aiberry, Inc.

What condition does NCT04994899 study?

NCT04994899 studies Depression, Anxiety, Healthy.

Is NCT04994899 still recruiting?

NCT04994899 is currently terminated. Last updated 9 June 2023.

Last reviewed 2023-06-09 · How we verify

NCT04994899

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Aiberry AI Mental Health Screening Platform

Terminated Last updated 9 June 2023

What this trial tests

trial in Depression in 800 participants. Terminated before completion.

Timeline

22 September 2022

Primary endpoint
6 April 2023

6 April 2023

Quick facts

Lead sponsor	Aiberry, Inc
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	800
Start date	22 September 2022
Primary completion	6 April 2023
Estimated completion	6 April 2023
Sites	3 locations across United States

Conditions studied

Depression — all drugs for Depression →
Anxiety — all drugs for Anxiety →
Healthy — all drugs for Healthy →

Sponsor

Aiberry, Inc

Who can join

Adults 13 to 79, any sex, with Depression or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aiberry is creating a multi-modal artificial intelligence (AI) platform that analyzes facial, audio and text features to screen for mental illness. This multicenter study will be used to collect data to validate the platform's ability to detect depression and anxiety in a diverse patient population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04994899 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aiberry, Inc
Last refreshed: 9 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04994899.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing